Avanos Medical (NYSE:AVNS) Reaches New 52-Week Low - Time to Sell?

Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) shares hit a new 52-week low on Monday . The stock traded as low as $13.87 and last traded at $14.30, with a volume of 165012 shares trading hands. The stock had previously closed at $13.95.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Avanos Medical from a "hold" rating to a "buy" rating in a research note on Wednesday, March 19th.

Avanos Medical Stock Down 3.5 %

The firm has a fifty day simple moving average of $15.53 and a 200 day simple moving average of $18.12. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The company has a market cap of $644.41 million, a PE ratio of 41.20 and a beta of 1.15.

Avanos Medical (NYSE:AVNS - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.03. The business had revenue of $179.60 million for the quarter, compared to analysts' expectations of $177.23 million. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. Equities research analysts predict that Avanos Medical, Inc. will post 1.32 EPS for the current year.

Remove Ads

Insider Buying and Selling

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the business's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $15.25, for a total transaction of $106,750.00. Following the completion of the sale, the senior vice president now owns 82,047 shares of the company's stock, valued at approximately $1,251,216.75. The trade was a 7.86 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 2.64% of the company's stock.

Institutional Trading of Avanos Medical

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Illinois Municipal Retirement Fund grew its stake in Avanos Medical by 3.1% during the fourth quarter. Illinois Municipal Retirement Fund now owns 25,236 shares of the company's stock worth $402,000 after buying an additional 748 shares during the period. Comerica Bank raised its stake in shares of Avanos Medical by 3.4% in the 4th quarter. Comerica Bank now owns 22,903 shares of the company's stock valued at $365,000 after acquiring an additional 755 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Avanos Medical by 3.6% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,834 shares of the company's stock valued at $411,000 after acquiring an additional 901 shares in the last quarter. EP Wealth Advisors LLC boosted its position in Avanos Medical by 14.6% during the 4th quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company's stock worth $161,000 after purchasing an additional 1,289 shares during the period. Finally, Gotham Asset Management LLC increased its holdings in Avanos Medical by 5.3% in the 4th quarter. Gotham Asset Management LLC now owns 28,234 shares of the company's stock valued at $449,000 after purchasing an additional 1,425 shares in the last quarter. Institutional investors and hedge funds own 95.17% of the company's stock.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.